Ronnie Rivany
Departemen Administrasi Kebijakan Kesehatan Fakultas Kesehatan Masyarakat Universitas Indonesia

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

Cost Recovery Rate Tarif Rumah Sakit dan Tarif INA-CBG’s Berdasarkan Clinical Pathway pada Penyakit Arteri Koroner di RS Pemerintah A di Palembang Tahun 2015 Mardiah, Mardiah; Rivany, Ronnie
Jurnal Ekonomi Kesehatan Indonesia Vol. 1, No. 4
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The difference of cost negative in the case of Coronary Artery Disease (CAD) with Percutaneous Coronary Intervention (PCI), indicate health financing gap between of hospital rates and INA-CBG’s rates. This study aimed to see the difference between the cost recovery rate (CRR) of hospital rates and INA-CBG’s rates for CAD with PCI at A Hospital. The results showed that the cost of treatment based on clinical pathways at the severity level I had a higher CRR Hospital rates compared to INA-CBG’s CRR, whereas at the severity level II, Hospital CRR rate was lower than INA-CBG’s CRR for the utility of less than 2 stents. At severity level III, CRR INA-CBGs’ rates with utilization of 1 and 2 stents performed higher rates than the hospitals CRR. This was related to INA-CBG’s rate that did not take the magnitude of the stentulitizationinto account. It is necessary to improve INA-CBG’s tarif development method from hospital base rate to clinical pathway-based cost of treatment in order to meet hospital operational cost and ensure the best quality of service
Indonesia Diagnosis Related Groups Rivany, Ronnie
Kesmas Vol. 4, No. 1
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Di Amerika dan Australia, Kelompok Diagnosis Terkait (Diagnosis Related Group’s ) (DRGs) adalah suatu cara mengidentifikasi dan mengelompokkan pasien yang mempunyai kebutuhan dan sumber yang sama dirumah sakit berdasarkan alur perjalanan klinis (Clinical Pathway ). Penyakit yang mempunyai co morbidity atau co mortality, disebut Casemixdan mempunyai kode yang memperlihatkan derajat keparahan kelompok penyakit sehingga secara linear akan mempengaruhi besaran biaya perawatan. Dengan demikian, pembayaran perawatan di rumah sakit akan dilakukan berdasarkan “kesembuhan“ (cost of treatment per diagnosis), dan bukan berdasarkan penggunaan pelayanan medis dan non medis (fee for services). Di Indonesia sampai kini belum ada model perhitungan biaya untuk pembayaran perawatan mulai pasien masuk sampai sembuh dan keluar rumah sakit berdasarkan diagnosis (cost of treatment per diagnosis). Pola pembiayaan yang digunakan di rumah sakit masih didasarkan pada fee for services. Dalam bentuk tesis, konsep Indonesia – DRG/ INA –DRG kami kembangkan di Fakultas Kesehatan Masyarakat Universitas Indonesia, mengacu pada Australian DRG. In America, and Australian, Diagnosis Related Groups, known as DRGs is a method to identify and classify inpatients that have the same resources within hospitals based on Clinical Pathway. It has numbering/coding system used like a menu for determining the cost. The co morbidity and/or co mortality of a di-sease is called the Casemix, where it has numbering/coding that shows the degree of severity, which the cost linearly increased. Therefore the financing is based on the in-patients’ ”recovery” (cost of treatment per diagnosis), and not based on the utility of the medical and non medical treatments (fee for services). One of the issues arise in Indonesia’s health financing system is that it does not have the costing model for health care financing, for inpatients from ad-mission to discharge (cost of treatment per diagnosis). Therefore the financing system used is based on fee for services. Using Australian DRG as reference, the concept of Indonesia–DRG / INA–DRG is developed by the researcher with Graduate Students in the Public Health and Hospital Administration Program, Postgraduate Studies Faculty of Public Health University of Indonesia, in Thesis.
Alur Klinis dan Biaya Pengobatan Rumatan Metadon di Rumah Sakit Ketergantungan Obat Jakarta Rivany, Ronnie
Kesmas Vol. 5, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Dampak penyalahgunaan narkoba antara lain adalah peningkatan prevalensi HIV/AIDS di kalangan pengguna narkoba suntik. Program Terapi Rumatan Metadon merupakan salah satu cara penanganan yang kini belum mempunyai alur klinis yang berfungsi menjamin standar kualitas pelayanan. Di samping itu, belum ada ketentuan yang dapat dijadikan acuan biaya pengobatan. Tujuan penelitian ini adalah membuat alur klinis dan biaya pengobatan rumatan metadon dan casemix di Rumah Sakit Ketergantungan Obat (RSKO) Jakarta. Metode penelitian merujuk INADRG yang berbasis evidence dengan diskusi kelompok, tenaga medis dan tenaga non medis serta profesi dan manajemen RSKO. Berdasarkan jumlah dan jenis utilisasi dalam alur klinis maka biaya pengobatan dilakukan dengan metode activity based costing dan simple distribution methode. Alur klinis yang diperoleh menunjukkan lama rumatan metadon 338 hari dengan casemix TBC, Hepatitis dan HIV/AIDS atau kombinasi. Biaya pengobatan rumatan metadon Rp.66.024.016, dengan casemix penyakit penyulit berkisar antara Rp. 70.156.705 hingga Rp.211.863.018 dan Rp. 84.875.621 hingga Rp. 226.988.354. dengan kombinasi penyakit penyulit dan penyerta. The drug abuse implicated in increasing HIV/AIDS prevalence among injection drug users. As an alternative treatment, Methadone Maintenance Treatment (MMT) have not yet equipped with clinical pathway that function as a tool for assuring the standard quality of services. Beside that, treatment cost as average standard cost of health care services. The purpose of this study were to design and apply clinical pathway and treatment cost of MMT along with its casemix in Drugs Dependence Hospital Jakarta (DDHJ). Method used were INA-DRG based on evidence from medical record and focus group discussion involving medical and non-medical staff, related professional organization and hospital management. Based on numbers and types of treatment utilizated in clinical pathway, treatment cost was calculated by using activity based costing with simple distribution method. This study found that the length of stay for MMTP was 338 days, casemix consisted of TB, Hepatitis, HIV/AIDS and its combination. Treatment cost for MMTP was IDR 66.024.016, casemix for complicating disease ranging from IDR 70.156.705 to IDR 211.863.018, and IDR 84.875.621 to IDR 226.988.354 for casemix combination of complicating and comorbidity diseases.